Bodyport
Digital therapeutics company providing easy-to-use cardiac scale for monitoring cardiorenal conditions. The scale detects signals through a person's feet and sends data to the clinical care team. Bodyport has received FDA clearance for its cardiac scale and aims to provide optimized interventions tailored to the patient. The company was founded in 2014 and headquartered in Mountain View, United States. It has raised…
Funding snapshot
About
Digital therapeutics company providing easy-to-use cardiac scale for monitoring cardiorenal conditions. The scale detects signals through a person's feet and sends data to the clinical care team. Bodyport has received FDA clearance for its cardiac scale and aims to provide optimized interventions tailored to the patient. The company was founded in 2014 and headquartered in Mountain View, United States. It has raised $15.8M in series a funding, with backing from Boehringer Ingelheim Venture Fund, Initialized Capital, Playground Global, Y Combinator, and others. The company operates in the Life Sciences - Cardiac and Vascular Disorders, HealthTech - Disease Self Management, High Tech - IoT Applications space. Its offerings span Wearable Technology - Health and Wellness Devices - Cardiac and Healthcare IT - Value Based Care - Remote.
Business model
Wearable Technology > Health and Wellness Devices > Cardiac,
Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > Device,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Cardiology,
Cardiac and Vascular Disorders > Medical Devices > Monitoring Devices > Cardiac Health,
Y Combinator Batches > 2015 > Summer
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.